Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
#AMRSOS! AMR could worsen, killing 39m during 2025-2050
Dear All, Just in time for the United Nations General Assembly High-Level Meeting on AMR, the team behind the global
Read More >
Lifeline, the Musical Story of Penicillin: A Review
Dear All, Last week I went to New York City to see one of the opening performances of Lifeline, The Musical, the
Read More >
WHO: AMR Policy Brief and Preclinical pipeline data call
Dear All, Supplementing and augmenting their review of the clinical and preclinical pipeline through 31 Dec 2023 (see the 15
Read More >
UK Subscription model goes live! Value bands cover entire UK!
Dear All (with thanks to Kevin for leading on this newsletter and with a wonkish / long-read alert on this
Read More >
Needles and haystacks: Preclinical antibacterial pipeline review
Dear All, Just published in AAC is WHO’s updated review of the global preclinical pipeline. Here are the links you
Read More >
Conflict-Borne XDR Superbugs: It’s Time for the PASTEUR Act!
Dear All: The recent publication of an exceptionally good plain-language summary of the AMR problem in Rolling Stone (yes, you
Read More >
ENABLE-2 funding now includes Hit Identification & Validation
23 July 2024 addenda x 2: Mark Blaskovich let me know that the CO-ADD project is still offering a free in
Read More >
NIAID/DMID thinking for FY2026: Antibacterials, Phage, and Antifungals
Dear All, NIAID’s DMID (Division of Microbiology and Infectious Diseases) recently held a council meeting during which they proposed program
Read More >
WHO Antibacterial Pipeline Review: Update thru 31 Dec 2023
Dear All, WHO have released an update through 31 Dec 2023 of their ongoing series of antibacterial pipeline reviews! Here
Read More >
The (confusing!) language of AMR: ChatGPT tries to help!
Dear All (Wonkish alert! Not technical but lengthy … so settle in and enjoy the ride!): Regular readers will know
Read More >
Mitigating environmental AMR: Grants from ICARS
Dear All, Our colleagues at ICARS have just announced a fascinating grant opportunity focused on environmental AMR. They don’t want
Read More >
Casting call: Lifeline (Sir Alexander Fleming, the musical)
Dear All, I have just learned that Lifeline, the musical formerly known as The Mould that Changed the World, is seeking scientists, medics, and healthcare
Read More >
Lancet series video tour / Japan’s 2021 PPL (Priority Pathogen List)
Dear All, As a follow-up to yesterday’s relatively wonkish newsletter, I thought I’d quickly point out two things that may
Read More >
Lancet: 10-20-30 targets to address AMR by 2030
Dear All (wonkish alert … but definitely worth the effort! Refill your coffee!),Ramanan Laxminarayan and about 40 colleagues from around
Read More >
WHO Bacterial Priority Pathogen List (PPL): 2024 update
Dear All, WHO have just released a 2024 update to their 2017 (bacterial) Priority Pathogen List (PPL)! Here are the
Read More >
Environmental, Animal, and Human Uses of Phage: WHO webinars
Dear All, I have just this weekend learned of a 3-part WHO webinar series on uses of phage. Two of
Read More >
New UK 5-year AMR plan: Subscription model details!
Dear All, Today is a newsletter double-header! Coming hard on the heels of the opportunity to support an ESCMID petition
Read More >
ESCMID’s UNGA 2024 Petition to EU Health Ministers: Sign and Send!
Dear All, During the GLG AMR (Global Leaders Group for AMR) event just before ECCMID (see the 3 May 2024 newsletter
Read More >
Path to UNGA 2024 as of 3 May 24 / Events on 14-15 May (DC, NYC)
Dear All, Well, ECCMID 2024 (Barcelona) has come and gone. I saw many of you there … but it’s always
Read More >
R&D Implications: Global Burden of Disease is 28% Infectious!
17 Sep 2024 update: This is now the second of a 3-part newsletter series! See also part 1 (“#AMRSOS! GRAM
Read More >